Sca-1(+) hematopoietic cell-based gene therapy with a modified FGF-2 increased endosteal/trabecular bone formation in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/17637718

Download in:

View as

General Info

PMID
17637718